Natixis’s Select Medical SEM Stock Holding History

Natixis’s Portfolio SEM Stock Details SEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-21,754	Closed	-$156K	–	966
2017 Q1	$156K	Buy	21,754 +193	+0.9%	+$1.4K	﹤0.01%	907
2016 Q4	$154K	Buy	+21,561	New	+$150K	﹤0.01%	837

Other funds holding SEM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

NTC

North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Natixis's SEM Position: Q2 2017 in Review

Natixis sold out of Select Medical (SEM) in Q2 2017, closing a stake of 21,754 shares — an estimated $156K sold.

Natixis first reported a position in SEM in Q4 2016 and held it in 2 quarters. The position peaked at $156K in Q1 2017. 155 funds tracked by Wall St. Rank hold SEM as of Q2 2017.

Natixis reported no remaining Select Medical position as of Q2 2017 after selling out during the quarter.
Natixis sold 21,754 Select Medical shares in Q2 2017, an estimated $156K.
Natixis first reported a position in Select Medical in Q4 2016 and held it in 2 quarters.
Natixis's Select Medical position peaked at $156K in Q1 2017.
155 funds tracked by Wall St. Rank held Select Medical as of Q2 2017.

Based on Natixis's 13F filing for Q2 2017, filed 14 Aug 2017.